Controls, standards, and histogram interpretation in DNA flow cytometry.

Publisher Summary This chapter presents technical details for controls, standards, and criteria used to evaluate and interpret DNA flow cytometry measurement (FCM) data that have proved efficient and reproducible. Guidelines proved to be useful in setting up DNA FCM methods in their laboratories and stimulate suggestions, improvements, and eventually standardization. Controls and standards as well as defined criteria to interpret DNA histograms are essential components of DNA FCM methodology. One of these controls is the cytologic or histologic examination of the specimen. This control is necessary for evaluating the quality of the specimen and for assessing the percentage of tumor versus nontumor cells present. Another control is microscopic review of the fluorescently stained cells or nuclei. This control provides information regarding the specific uptake of dye into the nucleus, integrity of cells or nuclei, and the degree of cell aggregation. Essential to the determination of relative DNA content is a DNA reference standard. Both internal and external standards have been used as normal DNA content reference standards from a variety of sources: chicken red blood cells (CRBC), trout red blood cells (TRBC), human peripheral blood lymphocytes (hPBL), and nonmalignant tissue from the same organ as the specimen. The chapter also discusses the evaluation of DNA histograms that involves the incorporation of defined parameters to allow consistency and quality control of data interpretation.

[1]  B. Dutrillaux,et al.  DNA content and genetic evolution of human colorectal adenocarcinoma. A study by flow cytometry and cytogenetic analysis , 1988, International journal of cancer.

[2]  F. Debruyne,et al.  Tissue‐specific markers in flow cytometry of urological cancers. III. Comparing chromosomal and flow cytometric dna analysis of bladder tumors , 1987, International journal of cancer.

[3]  W. McGuire,et al.  Evaluation of a modeling system for S-phase estimation in breast cancer by flow cytometry. , 1987, Cancer research.

[4]  W. Hiddemann,et al.  Convention on nomenclature for DNA cytometry , 1984 .

[5]  A. Jakobsen,et al.  The use of trout erythrocytes and human lymphocytes for standardization in flow cytometry. , 1983, Cytometry.

[6]  A. Howell,et al.  DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast. , 1987, British Journal of Cancer.

[7]  S. Rivkin,et al.  Short-term cryopreservtion of human breast carcinoma cells for flow cytometry† , 1985 .

[8]  A. Yoshiki,et al.  Strain specific sensitivity to diethylnitrosamine-induced carcinogenesis is maintained in hepatocytes of C3H/HeN⇔C57BL/6N chimeric mice , 1991 .

[9]  I. Christensen,et al.  A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. , 1983, Cytometry.

[10]  O. Laerum,et al.  Trout and salmon erythrocytes and human leukocytes as internal standards for ploidy control in flow cytometry. , 1987, Cytometry.

[11]  Bartow Sa,et al.  DNA flow cytometry in solid tumors: practical aspects and clinical applications. , 1989 .

[12]  D. Killander,et al.  Flow‐Cytometric DNA analysis in primary breast carcinomas and clinicopthological correlations , 1984 .

[13]  J. Winter,et al.  Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomas. , 1986, Cancer research.

[14]  C B Bagwell,et al.  A simple and rapid method for determining the linearity of a flow cytometer amplification system. , 1989, Cytometry.

[15]  M. Melamed,et al.  Accessibility of DNA in situ to various fluorochromes: relationship to chromatin changes during erythroid differentiation of Friend leukemia cells. , 1984, Cytometry.